Targeted Therapies in Oncology
February 2017
Volume: 6
Issue: 2
January 2017
Volume: 6
Issue: 1
November 2016
Volume: 5
Issue: 8
October 2016
Volume: 5
Issue: 7
September 2016
Volume: 5
Issue: 6
July 2016
Volume: 5
Issue: 5
May 2016
Volume: 5
Issue: 4
April 2016
Volume: 5
Issue: 3
March 2016
Volume: 6
Issue: 2
January 2016
Volume: 5
Issue: 1
November 2015
Volume: 4
Issue: 8
October 2015
Volume: 4
Issue: 7
September 2015
Volume: 4
Issue: 6
July 2015
Volume: 4
Issue: 5
May 2015
Volume: 4
Issue: 4
April 2015
Volume: 4
Issue: 2
November 2014
Volume: 3
Issue: 6
September 2014
Volume: 3
Issue: 5
July 2014
Volume: 3
Issue: 4
May 2014
Volume: 3
Issue: 3
March 2014
Volume: 3
Issue: 2
January 2014
Volume: 3
Issue: 1
November 2013
Volume: 2
Issue: 6
September 2013
Volume: 2
Issue: 5
July 2013
Volume: 2
Issue: 4
May 2013
Volume: 2
Issue: 3
March 2013
Volume: 2
Issue: 2
January 2013
Volume: 2
Issue: 1
November 2012
Volume: 1
Issue: 4
September 2012
Volume: 1
Issue: 3
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Improving Survival, Quality of Life, and Cost-Effectiveness for Allo-HCT
2
Real-World Data Show T-DXd Activity in HER2-Mutant NSCLC
3
FDA Panel Votes 10-3 In Favor of RP1 Plus Nivolumab for Advanced Melanoma
4
Durable Responses Seen With Cretostimogene in BCG-Unresponsive NMIBC
5